Several adverse health effects (including cancer and noncancer effects) may be the result of an imbalance between exogenous and endogenous invading substances and defense mechanisms. In these cases the probability of an adverse effect depends on how much the exposure to a substance increases or decreases the number of defenders or their efficiency as well as increasing or decreasing the number of invaders. Rather than using a dose scale such as parts per million or milligram/kilogram/day in these cases, dose-response models can directly incorporate the impact of defense mechanisms by using a dose scale that corresponds to the number of invaders that break through the defenders and become free to do their damage. The number of breakthroughs at a specific age, the cumulative number of breakthroughs by a specific age, or the cumulative number of breakthroughs in a window of time would usually be the appropriate age-dependent dose. Although a lifetime average daily dose level can be used as a surrogate for an age-dependent dose in simplistic dose-response models, the age-dependent dose itself can be used in more biologically based models that include time, reflect the key role of feedback mechanisms, and treat the human body as an agedependent dynamic system responding to internal and external stimuli and not as a system at equilibrium. Some illustrative biologic examples of defense mechanisms and invader-defender interactions are presented. Several numerical examples are given in which the dose incorporates the age-dependent effects of a substance on the number of invaders, the number of defenders, and/or the defenders' efficiencies.
Introduction
Health is a balance between harmful and helpful forces. This balance can be modeled by considering the relative proportions of invaders and defenders and an individual defender's efficiency in defeating a single invader.
Several adverse health effects (including both cancer and noncancer effects) may be the result of an imbalance between exogenous and endogenous invading substances and defense mechanisms. Opposing forces are involved in most normal physiologic processes as well as in abnormal processes such as cancer, infectious diseases, immune system disorders, neurotoxicity, organ toxicity, adverse reproductive effects, teratogenesis, and developmental problems.
Most chemicals are considered to be invaders although their metabolism by defense enzyme systems is usually to less toxic metabolites. The cytochrome P450 system is one such system that is induced at low-level exposures-in some cases this is the earliest measure of exposure. This induction is also related to the increased synthesis of ascorbic and glucaric acids in the liver, and both of these acids can inhibit certain steps of the carcinogenic process. Another important defense mechanism in this process is cell-cycle arrest or apoptosis depending on the degree of activation of the p53 gene. There are many examples of enhanced defenses relating to the immune system. The responses of the whole organism can be modified by lifestyle changes, regular aerobic exercise, diet content, caloric restriction, supplementation with antioxidants (including green tea and other plant sources of flavonoids), degree of stress, etc. Examples such as these show that the carcinogenic process is subject to substantial forces in both directions and also that the impact of these forces may be time dependent.
Invaders and Defenders
The invaders/defenders concept is quite intuitive. Invaders (e.g., molecules of a toxic chemical) enter the body or a specific tissue or cell and try to attack a system, a tissue, or a cell component. Each defender (e.g., an individual molecule or larger component of the defense mechanisms of the cell, tissue, or body) has a probability of preventing an individual invader from successfully attacking its target. The defeat of an invader is a broad idea encompassing the interaction of molecules, cells like phagocytes, the storing of damage in a harmless form such as in the case of cellcycle arrest, or the elimination of damage (e.g., apoptosis).
For the numerical examples in this paper, the rules of combat between invader and defender are as follows; however, these rules could be modified if appropriate. An invader must successfully escape defeat at the hands of each available defender. When an invader confronts a defender, the defender has a specified probability of defeating (neutralizing or destroying) the invader-for simplicity this probability is called the defender's efficiency and is denoted mathematically as DE. Thus, if the initial number of defenders is ND, the probability that the first invader is not defeated by any of the initial ND is (1-DE)ND. If the invader is not defeated by any available defender, the invader is said to have broken through the defense system and is free to damage its target. If an invader is defeated by a defender, that defender is used up and is not available to confront the next invader. Thus, if the number of invaders, NI, is large and several of the early invaders are defeated, later invaders face fewer defenders and have a greater probability of breakthroughs. The total number of breakthroughs, NB, is a random variable that depends on the NI, the ND, and the DE.
Therefore, for a given number of invaders the number of breakthroughs increases as the number of defenders decreases and vice versa ( Figure 1) . Similarly, the number of breakthroughs increases as the individual defender's efficiency decreases and vice versa ( Figure 2 ).
Monte Carlo simulation routines can be used to determine large numbers of random realizations of the age-dependent number of breakthroughs as well as to estimate the age-dependent expected number of breakthroughs (i.e., the mean number of breakthroughs at a particular age). The agedependent expected number of breakthroughs is an age-dependent single number summarization of the stochastic interaction between invaders and defenders and the resultant random number of breakthroughs. In the discussions that follow, the term number of breakthroughs is interpreted as either a large number of random realizations of the age-dependent series of numbers of breakthroughs or the age-dependent expected number of breakthroughs. In the numerical examples the number of breakthroughs is the age-dependent expected number of breakthroughs. 
Figures 3 and 4 give a simple illustration of this type of dose relationship; i.e., how the probability PD) of an adverse health effect would change as the administered dose D changes. In Figure 3A the number of invaders increases linearly with D, whereas there is a saturable increase in the number of defenders with D. Figure 3B shows how the resulting number of breakthroughs changes as D changes. Figure 4 shows Two additional examples of general dose-response models including the invaders/defenders concept and an agedependent number of breakthroughs are described in this section.
As is frequently done in human epidemiologic modeling, the age-dependent probability of an adverse health effect can be modeled as a proportional hazards model in which the age-dependent multiplier of the age-dependent background hazard rate is a function of the age-specific dose-here the age-specific dose would be the age-specific number of breakthroughs. In such doseresponse models, the probability (P[ TE D(t), t= 0,..., 71, which for simplicity is denoted by P[ T; D(t)]), of a specified adverse health effect by age Twhen the age-dependent administered dose is D(t) at 
NJ[t, D(t)] = NIO(t) + ANI[D(t)] ND[t, D(t)] = ND0(t) + AND[D(t)].
Alternatively, the age-dependent probability of an adverse health effect can be modeled with the hazard rate for the adverse health effect being the sum of an age-dependent background hazard rate and an administered-dose-dependent hazard rate. The administered-dose-dependent hazard rate would depend on the administered dose through the impact of the administered dose on the number of breakthroughs. In such dose-response models, the probability (P[T; D(t)]) of a specified adverse health effect by age 
Model Components and Their Combinadon
The output of the dose-response model is the probability of a specified adverse health effect for a specified administered dose. This output will usually be expressed as an added risk, namely, added risk at age T= P[ T;
which is the increase in the probability of a specified adverse health effect for an administered dose history of D( T) compared to the same probability for dose zero.
The ultimate input to the dose-response model is the number of breakthroughs. The model components and their combination to determine the added risk of a specified adverse health effect are illustrated in Figure   5 . The inputs determining the number of breakthroughs are the age-dependent background number of invaders, age-dependent background number of defenders, agedependent individual defender's efficiency, age-dependent relationship between the administered dose and additional number of invaders, age-dependent relationship between administered dose and additional number of defenders, and age-dependent administered dose.
The impact of the age-dependent administered dose is to determine the agedependent additional number of invaders and defenders.
The age-dependent additional number of invaders and defenders combine with their respective background numbers to determine the age-dependent total number of invaders and the age-dependent total number of defenders.
The age-dependent total number of invaders and defenders and the agedependent individual defender's efficiency combine to determine the age-dependent number of breakthroughs.
Finally, the age-dependent number of breakthroughs determines the age-dependent added risk ofa specified adverse health effect.
Numerical Examples
For the invaders/defenders concept to become a practical tool for dose-response estimation and generation of research strategies, tools must exist that allow a risk assessor or researcher to determine the quantitative values of the numbers of breakthroughs and added risks associated with different specific numerical values for the components of the invaders/defenders paradigm. Figures 6 through 11 are specific numerical examples of applying the general methodology illustrated in Figure 5 for specifying the components of the invaders/defenders paradigm and combining them to determine the added risk of a specified adverse health effect.
Although the primary importance of Figures 6 through 11 is to prove that the invaders/defenders concept is a practical, implemented, and available approach to dose-response estimation and generation of research strategies, the examples in the figures are themselves somewhat interesting. They illustrate what happens in several situations. For example, * when the number of defenders decreases with age ( Figure 6 ); * when the number of defenders is affected by feedback ( Figure 7) ; * when the administered dose has different age dependencies ( Figure 8 ); * when the individual defender's efficiency decreases with age ( Figure 9) Figure 10) ; and * when the administered dose affects the numbers of both the invaders and defenders and the magnitude of an ageindependent administered dose changes (Figure 1 1) .
Generalizations
There are several generalizations of the implementation of the invaders/defenders concept described above. One O<t. T
Conclusions
Species and strain differences in the frequencies of adverse health effects could be explained by species and strain differences in the number of invaders, the number of defenders, the individual defender's efficiency, their age dependencies, and their administered-dose dependencies. The concept of invaders and defenders is presented to stimulate interest in the multifactorial nature of the dose and doseresponse modeling of adverse health effects and to highlight the fact that defense mechanisms can play a major role in determination of the frequency of adverse health effects. It can be predicted, for instance, that an increase in tumor incidence may occur without additional exposures to carcinogens if an organism's defenses are depleted. This side of the balance is not normally considered in the modeling of the carcinogenic process. We were surprised by the number of factors that may produce hormetic effects in simulations. This suggests that hormesis may be more widespread than generally recognized but that it may be confined to a range of doses that perhaps fall below those commonly employed in chronic bioassays, particularly if only the maximum tolerated dose and half this dose are used.
In the past it has been assumed (with less than critical reasoning) that for some adverse health effects like cancer, low-dose linearity would be a general phenomenon. The invaders/defenders model indicates that even if the formation of DNA adducts is linear, there are many other factors that may lead to low-dose nonlinearity or even hormetic responses.
The concept of invaders and defenders has a high degree of practical importance for the evolution of attitudes toward the reduction of the incidence of adverse health effects. It 
